Timely guidelines, regularly updated: COVID-19, C. difficile, and beyond
Dear All, During the 18-19 Nov 2019 FDA-IDSA-NIAID-Pew workshop on ways to enhance antibacterial research (link), we spent some time discussing the slow pace of
4 May 2020
No Comments